BioCentury | Sep 11, 2020
Product Development

Yale’s Akiko Iwasaki shows SARS-CoV-2 invades neurons

...and Merck starts vaccine study By Sandi Wong, Assistant Editor SARS-CoV-2 in neuronsScientists led by Yale University’s...
BioCentury | Sep 10, 2020
Product Development

Having touched the third rail of data sharing in the pandemic, drug developers should hold on tight

...investigators. J&J has a partnership with the Yale University...
...1 C. Simone Fishburn Critical Path Institute TransCelerate BioPharma Inc. Vivli bts2020 bts20feed bts20ds COVID-19 covid19 data sharing Yale University...
BioCentury | Aug 29, 2020
Product Development

Next-wave Th1 cytokine cancer therapies aim for more precise targeting

...immune activation. Ring, an assistant professor at Yale University...
BioCentury | Aug 18, 2020
Product Development

SalivaDirect slots into growing matrix of resource-saving COVID-19 tests

...in a high complexity CLIA lab.Researchers from Yale University...
...is under FDA review. Karen Tkach Tuzman Becton Dickinson Color Genomics Quidel Yale University RT-PCR LAMP SalivaDirect COVID19 chs2020 cov19count cov19dx cov19count...
BioCentury | Jul 31, 2020
Product Development

U.K. locks down access to recombinant protein vaccine via GSK, Sanofi deal, its fourth for COVID-19

...syndrome or autosomal dominant polycystic kidney disease (see “Reata Rebound” ). Longitudinal immune differences Separately, Yale University’s...
BioCentury | Jul 3, 2020
Finance

On heels of $100M raise, Annexon joins burgeoning IPO queue

...to treat ENPP1 and ABCC6 deficiencies. The biotech has exclusive rights to the therapy from Yale University...
BioCentury | Jun 25, 2020
Emerging Company Profile

Simcha launches with $25M WuXi-led series A, new take on IL-18 for cancer

...Gu serve on Simcha’s board. The New Haven-based company was founded and is chaired by Yale University...
...technology: Yale University Disease focus: Cancer Clinical status: Preclinical Founded: 2018 by Aaron Ring University collaborators: Yale University...
...Programmed cell death 1 SIRPA (CD172a; SHPS-1) - Signal regulatory protein α Sandi Wong, Assistant Editor Yale University Interleukin-18...
BioCentury | Jun 23, 2020
Politics, Policy & Law

Scientists warn Trump immigration ‘pause’ will harm biopharma innovation

...spouses and children, many of whom also compete against American workers,” it said. Steve Usdin, Washington Editor Yale University Howard...
BioCentury | Jun 20, 2020
Translation in Brief

CAR Ts against senescent cells; plus NIH program for ALS, sex-dependent COVID-19 immune responses and more

...biological similarities between ALS and other neurodegenerative diseases. COVID-19 immune response differs by sex A Yale University...
BioCentury | May 9, 2020
Deals

Columbia’s peptide nucleic acid technology draws Fortress into rare discovery deal

...Inc. is the newest home of a gene editing technology from Peter Glazer’s lab at Yale University...
Items per page:
1 - 10 of 462
BioCentury | Sep 11, 2020
Product Development

Yale’s Akiko Iwasaki shows SARS-CoV-2 invades neurons

...and Merck starts vaccine study By Sandi Wong, Assistant Editor SARS-CoV-2 in neuronsScientists led by Yale University’s...
BioCentury | Sep 10, 2020
Product Development

Having touched the third rail of data sharing in the pandemic, drug developers should hold on tight

...investigators. J&J has a partnership with the Yale University...
...1 C. Simone Fishburn Critical Path Institute TransCelerate BioPharma Inc. Vivli bts2020 bts20feed bts20ds COVID-19 covid19 data sharing Yale University...
BioCentury | Aug 29, 2020
Product Development

Next-wave Th1 cytokine cancer therapies aim for more precise targeting

...immune activation. Ring, an assistant professor at Yale University...
BioCentury | Aug 18, 2020
Product Development

SalivaDirect slots into growing matrix of resource-saving COVID-19 tests

...in a high complexity CLIA lab.Researchers from Yale University...
...is under FDA review. Karen Tkach Tuzman Becton Dickinson Color Genomics Quidel Yale University RT-PCR LAMP SalivaDirect COVID19 chs2020 cov19count cov19dx cov19count...
BioCentury | Jul 31, 2020
Product Development

U.K. locks down access to recombinant protein vaccine via GSK, Sanofi deal, its fourth for COVID-19

...syndrome or autosomal dominant polycystic kidney disease (see “Reata Rebound” ). Longitudinal immune differences Separately, Yale University’s...
BioCentury | Jul 3, 2020
Finance

On heels of $100M raise, Annexon joins burgeoning IPO queue

...to treat ENPP1 and ABCC6 deficiencies. The biotech has exclusive rights to the therapy from Yale University...
BioCentury | Jun 25, 2020
Emerging Company Profile

Simcha launches with $25M WuXi-led series A, new take on IL-18 for cancer

...Gu serve on Simcha’s board. The New Haven-based company was founded and is chaired by Yale University...
...technology: Yale University Disease focus: Cancer Clinical status: Preclinical Founded: 2018 by Aaron Ring University collaborators: Yale University...
...Programmed cell death 1 SIRPA (CD172a; SHPS-1) - Signal regulatory protein α Sandi Wong, Assistant Editor Yale University Interleukin-18...
BioCentury | Jun 23, 2020
Politics, Policy & Law

Scientists warn Trump immigration ‘pause’ will harm biopharma innovation

...spouses and children, many of whom also compete against American workers,” it said. Steve Usdin, Washington Editor Yale University Howard...
BioCentury | Jun 20, 2020
Translation in Brief

CAR Ts against senescent cells; plus NIH program for ALS, sex-dependent COVID-19 immune responses and more

...biological similarities between ALS and other neurodegenerative diseases. COVID-19 immune response differs by sex A Yale University...
BioCentury | May 9, 2020
Deals

Columbia’s peptide nucleic acid technology draws Fortress into rare discovery deal

...Inc. is the newest home of a gene editing technology from Peter Glazer’s lab at Yale University...
Items per page:
1 - 10 of 462